Massachusetts Governor Seeks Easier Medical Marijuana Access for Veterans
Last Updated
Veterans treated at VA facilities could join the Massachusetts medical cannabis program by submitting official federal records of a qualifying diagnosis, under a proposal from Gov. Maura Healey.
Veterans who get their care through the U.S. Department of Veterans Affairs could soon qualify for Massachusetts’ medical cannabis program without visiting a second doctor, under a proposal filed by Gov. Maura Healey.
The provision is tucked into a supplemental budget bill the governor sent to the Legislature last week. It would allow the Cannabis Control Commission to issue a medical registration card to a veteran who submits official VA documentation showing a diagnosis of a debilitating medical condition. Those patients would not need a written or electronic certification from a healthcare professional licensed to recommend cannabis in Massachusetts.
That extra certification is the barrier Healey is trying to remove. Federal rules still treat cannabis as a Schedule I drug. VA providers may talk with patients about marijuana use, but they cannot fill out the recommendation forms state medical programs require. Veterans who already have a qualifying diagnosis inside the VA system are therefore told to find an outside clinician, pay for a cannabis-specific visit, and repeat the process when the certification expires. Some do. Others stay out of the medical program and buy in the adult-use market, or they do without legal access.
Healey’s language would treat the VA diagnosis as the medical record the state needs. A VA doctor would not be asked to recommend cannabis or sign a Massachusetts form. The veteran would still have to register with the commission, obtain a state medical card, and follow program rules. Cannabis would remain banned on VA property. The proposal is a state workaround, not a change in federal clinical policy.
The bill would also expand what Massachusetts counts as a “debilitating medical condition.” Statute now lists cancer, glaucoma, HIV/AIDS, hepatitis C, ALS, Crohn’s disease, Parkinson’s disease and multiple sclerosis, and it lets clinicians certify other conditions in writing. Healey would add post-traumatic stress disorder and medical conditions that produce chronic pain to the named list. Both are common among veterans and already appear in many certifications under the existing catch-all language. Putting them in the statute would make eligibility less dependent on an individual provider’s judgment.
Similar ideas have been circulating on Beacon Hill for several sessions. Earlier bills would have accepted VA paperwork in place of a state recommendation and would have named PTSD more clearly. Those measures advanced in committee but did not become law. Placing the veterans language in a budget bill gives it a different legislative vehicle and a different set of competing priorities.
If the section survives, the commission would have to build a process for reviewing VA records and issuing cards without a certifying-provider signature. Other patients would still need a Massachusetts recommendation. The change would not legalize cannabis at the VA, alter federal benefits, or require VA clinicians to change how they practice. It would only stop the state from demanding a second medical opinion that federal doctors are forbidden to give.
Supporters argue the current system charges veterans for paperwork their own healthcare system already produced. Opponents of broader medical access have long cited federal conflict, limited research and workplace concerns. Healey’s proposal does not resolve those debates. It answers a narrower question: whether a documented VA diagnosis of a qualifying condition should be enough to open the Massachusetts medical cannabis program.
The Legislature will decide whether that language stays in the budget package. For veterans who already carry a VA diagnosis and want a state medical card, the difference would be practical. They would bring federal records to a state agency instead of paying another clinician to restate what the VA has already found.